Podcasts about commercial operations

This is the time of year when we share with you some excerpts from the most recent University of South Carolina Darla Moore School of Business Economic Outlook Conference. Today's excerpt comes from Cody Thacker, Vice President of Commercial Operations, Scout Motors.

The NMIA, inaugurated by Prime Minister Narendra Modi on 8 October, is expected to serve passengers from Navi Mumbai along with neighbouring areas— Thane, Raigad, Pune and parts of the Konkan region. It will be operated by the NMIAL which is also an Adani Subsidiary. Watch Kasturi Walimbe explain the details of operations in #ThePrintVideo

Space lasers again! Odysseus Space from Luxembourg focuses on providing optical communications solutions between Space and Earth as a service. If you seem to notice that is not the first episode on optical communications, you're right – I think this will be a potentially very big theme going forward. Our guest this week is Odysseus' CEO & Co-Founder Jordan Vannitsen. Enjoy!

Text us your questions and thoughts!Sometimes the fastest way to grow your influence isn't chasing a bigger title,  it's expanding your understanding of how the business actually works.In this episode, we sit down with Emily Nguema, Senior Manager, Commercial Operations at Relay Technologies, to unpack her non-linear journey from studying languages and doing humanitarian work in Ecuador to partner success, edtech, and ultimately a far-reaching role in commercial operations. Through every pivot, one thread stays constant: value - how to define it, measure it, and translate it into stories executives can do something with.We explore:What it really looks like to shift from senior CSM to commercial opsHow embracing ambiguity becomes a competitive advantage in fast-moving orgsEmily's personal operating system (weekly roadmaps, calendar-bound priorities, and celebrating small wins like it's a sport)Humility as the hidden accelerator for influence and leadershipCareer decisions that prioritize learning, exposure, and meaningful impact over titlesYou'll also hear a fresh take on consultative customer success, executive-ready storytelling, and the mindset shift that helps CS professionals influence at higher levels (long before they have a formal leadership title).If you're eyeing a move into operations, or simply want your customer success strategy to resonate in the boardroom, this episode will give you both the frameworks and the courage to go for it.And if this conversation sparked something for you, share it with a colleague or teammate who needs the boost today.

Shoot us a Text.Episode #1213: Today we're talking Scout's aggressive service-first launch strategy, Carvana's stunning rise past Detroit's giants as it joins the S&P 500, and Waymo's shift from polite AV to confidently assertive city driver.Show Notes with links:Scout Motors is doubling down on a factory-run service network as it preps for a 2027 U.S. launch, betting that premium, reliable service will become a differentiator in the direct-to-consumer EV space.Scout will open 25 brand-owned rooftops at launch, both “Studios,” where customers shop and interact with a sales adviser, and “Workshops,” where service is performed. 57 rooftops are planned in Year 2.The brand plans 15% more annual service labor capacity than projected need to stay ahead of demand and reduce wait times.Scout aims to staff 1,400 service bays with roughly 900 technicians within five years, backed by VW Group resources but operating independently.“The way we describe our retail operations is a digital-first experience built on a service-first infrastructure.” — Cody Thacker, VP Commercial Operations, ScoutCarvana's comeback is officially Wall Street-certified as the online used-car disruptor joins the S&P 500, marking a stunning rebound from near-bankruptcy to an $87B valuation that now eclipses Ford and GM.Shares have surged more than 8,000% since 2022 and nearly doubled in 2025 as demand rebounded and cost discipline kicked in.Carvana now trades at 57× forward earnings, massively outpacing Detroit's single-digit multiples.The company sold a record 155,941 units in Q3, driving 55% revenue growth and fueling analyst confidence in potential volume leadership over CarMax by 2026.Index inclusion on Dec. 22 is expected to trigger significant buying from funds tracking the S&P.Waymo's once overly-courteous robotaxis are getting a software personality shift in San Francisco—assertive, human-like driving that's raising eyebrows, improving flow, and occasionally bending rules.Riders report more aggressive lane changes, quicker merges, and tighter gaps—closer to how real-world urban drivers operate.The shift follows complaints that overly passive AVs caused congestion, got stuck behind obstacles, and struggled downtown.Recent incidents include an illegal U-turn, a lane-change with no signal, and even a tragic neighborhood cat strike—fueling debate over “too human” behavior.Waymo says more assertiveness is required to scale in busy cities, with updates teaching AVs to make “common-sense decisions” when laws conflict.Thank you to today's sponsor, Mia. Capture more revenue, protect CSI, and never miss a call or connection again with 24/7 phone coverage and texting (SMS) follow-up for sales, service, and reception. Learn more at https://www.mia.inc/Join Paul J Daly and Kyle Mountsier every morning for the Automotive State of the Union podcast as they connect the dots across car dealerships, retail trends, emerging tech like AI, and cultural shifts—bringing clarity, speed, and people-first insight to automotive leaders navigating a rapidly changing industry.Get the Daily Push Back email at https://www.asotu.com/ JOIN the conversation on LinkedIn at: https://www.linkedin.com/company/asotu/

Marc Esteve, Executive Director of Commercial Operations at BEEAH, explains the exciting plans for BEEAH to pursue the service industry, providing an added sustainable touch to household services that the Sharjah community will cherish alongside innovative and futuristic technologies. Listen to #Pulse95Radio in the UAE by tuning in on your radio (95.00 FM) or online on our website: www.pulse95radio.com ************************ Follow us on Social. www.facebook.com/pulse95radio www.twitter.com/pulse95radio

On a trip to Basel, Switzerland, Philip catches up with Stefano Portolano, CEO of the European firm Azafaros. They chat about Azafaros' massive $147M Series B round in May 2025, which is being used to develop a small molecule treatment for rare diseases known as lysosomal storage disorders.Stefano also explains how rare diseases went in and out of fashion with big pharma, the revival of small molecule drugs relative to gene therapies and biologics, and his extensive experience in big biotech firms.⭐️ ABOUT THE SPEAKERWith more than 20 years of experience in orphan diseases under his belt, Stefano Portolano joined Azafaros in 2021. He previously served as Vice President, Strategy & Commercial Operations at Celgene and Head of Europe at Ultragenyx Pharmaceuticals.Stefano first received his Doctor of Medicine from Università degli Studi di Napoli ‘Federico II,' Italy and carried out research in autoimmunity as an adjunct assistant professor of Medicine at the University of California, San Francisco, USA.

Tune in for a conversation with David Dorman, Director of Commercial Operations at APR Energy. David shares how mobile gas-turbine solutions deliver hundreds of megawatts “behind the meter,” enabling data centers and municipalities to bridge grid delays, accelerate AI and cloud expansion, and meet surging energy demands. From disaster recovery projects in Puerto Rico to modular power strategies for hyperscale growth, this conversation reveals how converging energy and digital networks power the future of connectivity.

The Dell Technologies Forum took place today at the RDS in Dublin with Peter O'Mahony, former Ireland rugby captain and Grand Slam winner, Lynne Cantwell, most capped Irish women's rugby player and Head of Women's Strategy at the IRFU, David Humphreys, former Ireland international and Performance Director at the IRFU headlining the event which showcased how AI can help organisations drive peak performance, increase productivity and spark innovation. The Forum brought together approximately 600 of business and IT leaders to explore the latest developments in AI-powered transformation, the next generation of AI PCs, modern data centres and multicloud strategies. Conversations centred on how these advances can help strengthen competitiveness and unlock new growth opportunities. Across the keynote, solutions expo, curated breakout sessions, insightful panels and more, decision makers heard from a range of exciting experts and speakers on the innovative solutions that can empower them to transform at speed and scale up their success. This comes as Dell's Innovation Catalyst Study 2025 revealed that while 76% of Irish organisations view AI as a strategic driver of business growth, almost half (46%) are struggling to keep pace with rapid technological change and concerns around security, expertise and compliance. Peter O'Mahony took to the stage to share lessons from elite sport on building a high-performance culture on and off the pitch, while Lynne Cantwell and David Humphreys discussed how teamwork, leadership and innovation can help organisations thrive in an era of technological transformation. Other speakers included Jason Ward, EMEA North Vice-President and Managing Director of Dell Technologies Ireland; Alyssa Boyle, Head of Commercial Operations at Studio Ulster; and Gemma Leo, Head of Business Support & Projects at the Crann Centre. Speaking at the Dell Technologies Forum, Mark Hopkins, General Manager of Dell Technologies Ireland, said: "AI is no longer a question of "if" - it's a question of how to make it work better, faster, and more securely to provide the right outcomes for your business. Leaders across Ireland are now looking to scale AI responsibly, modernise infrastructure and prepare their workforce for what's next. Through this year's Dell Technologies Forum, we're bringing together the technologies, insights, and collaborations that help businesses turn ambition into action. Whether it's scaling GenAI, modernising infrastructure, or empowering the workforce with AI-enabled devices, the Forum is where organisations see what's possible - and how to make it real. "The insights of Irish rugby legends, alongside leading voices from the technology and business sectors, highlighted how teams can achieve peak performance - whether on the field or in the boardroom. At Dell Technologies Ireland, we are committed to helping organisations across the country harness AI and emerging technologies to innovate with confidence and turn potential into tangible results." To find out more about the Dell Technologies Forum, click here. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie now to find out more about how we can help you reach our audience. You can also find and follow us on Twitter, LinkedIn, Facebook, Instagram, TikTok and Snapchat.

In an engaging episode of the Female Auto Connect Podcast, we were joined by Åsa Borg from Polestar's global Group Management. Our conversation delved into the recent challenges facing the electric vehicle (EV) and broader automotive industry. Åsa provided valuable insights into how Polestar is navigating these market dynamics, outlining the strategies the company is implementing to stay ahead in a competitive landscape. She also shared a candid look at her experience in top management, offering a unique perspective on what it takes to lead at an innovative, up-and-coming automotive brand. Hosted on Acast. See acast.com/privacy for more information.

In an engaging episode of the Female Auto Connect Podcast, we were joined by Åsa Borg from Polestar's global Group Management. Our conversation delved into the recent challenges facing the electric vehicle (EV) and broader automotive industry. Åsa provided valuable insights into how Polestar is navigating these market dynamics, outlining the strategies the company is implementing to stay ahead in a competitive landscape. She also shared a candid look at her experience in top management, offering a unique perspective on what it takes to lead at an innovative, up-and-coming automotive brand.

On this episode of The Vitamin Professor Podcast, Professor Gene Bruno talks to Rick Handel of VITAQUEST. Rick Handel is a 50-year veteran of the nutraceutical industry, with a strong background in formulation, R&D and GMP manufacturing of dietary supplements. Rick is celebrating 30 years with industry-leading supplement manufacturer Vitaquest International, where he currently serves as Senior Vice President of Commercial Operations. In that capacity, Rick is responsible for driving sales and innovation by identifying and developing new strategies, business opportunities, science-backed ingredients and novel delivery technologies. Rick holds eight patents, is a published author, and has presented his scientific papers and studies at conferences around the world.This podcast is brought to you in partnership with VRM Media and Nutraland USA, Inc.For more information about our host and guest, please see the below information.https://vitaquest.com/https://nutralandusa.com/https://www.linkedin.com/in/rickhandel/https://www.linkedin.com/in/dr-gene-bruno-dbm-ms-rh-ahg-2ab0508/www.vrmmedia.com@hnvirtual, #hnvirtual, #rickhandel, #vitaquest, #genebruno, #thevitaminprofessorFind our podcast on your favorite platform:podcasts.apple.com/us/podcast/the-vitamin-professor-podcast/id1746137375youtube.com/channel/UCxeQ-IuqCRmq0YLc7jQNMKAmusic.amazon.com/podcasts/a8a96593-b93c-48cf-9fe9-2891c4035dad/the-vitamin-professor-podcastiheart.com/podcast/269-the-vitamin-professor-podc-175888136/

What do rocket science and commercial operations have in common? More than you think!In this episode, Mir Zaman, Vice President of Commercial Operations at Spectrum Brands, shares what he brought with him from the aeropsace industry to Amazon—and now to one of the most diverse brand portfolios in consumer goods. From challenging legacy systems to scaling creative content across categories like pet care, home improvement, and garden, Mir offers a clear blueprint for modern growth.We also dive into:Lessons from nearly a decade at Amazon (and how to keep that entrepreneurial spirit alive in big companies)Building a center of excellence that still feels like part of the teamThe power of two-way door decisions—and knowing when to test, pivot, or go all-inWhy AI will only work in CPG if it's tailored to different stages of maturityConnect with Mir on LinkedInFollow Beyond the Shelf on LinkedInLearn More about It'sRapidGet the It'sRapid Creative Automation PlaybookTake It'sRapid's Creative Workflow Automation with AI surveyEmail us at sales@itsrapid.io to find out how to get your free AI Image AuditTheme music: "Happy" by Mixaud - https://mixaund.bandcamp.comProducer: Jake Musiker

In 2025, we're embarking on a MedDevice Training Journey: From clinical trials to standard of care. Join us all year long as we explore training at each stage of the product life cycle.Need help developing your clinical trial training strategies? Contact us at training@cumbyconsulting.com.Related Resources:Tony Recupero is President, Commercial Operations of SI-BONE. Tony leads SI-BONE's commercial operations, including sales, market access, reimbursement, professional education and international. He is a proven commercial leader, responsible for the company's go to market strategy that has led to exponential revenue growth. Prior to SI-BONE, Tony was formerly the President of Catalyst Performance Advisors where he advised several medical device companies on commercial strategy. Tony was previously President and CEO of Baxano, Inc. Tony was also the Vice President of Sales for Kyphon from startup in 1999 through the end of 2004. Kyphon was acquired by Medtronic for $4.2 billion dollars. Early in his career, Tony progressed to senior sales management roles at United States Surgical Corporation and Sulzer Spine-Tech, Inc. Tony earned a B.A. in Communications from State University of New York at Albany and attended The General Management program at Harvard Business School.Subscribe to our newsletter to hear more about the journey from clinical trials to standard of care! Click here to subscribe! Connect with us on LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Tony Recupero⁠⁠⁠⁠Cumby Consulting⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Rachel Medeiros⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Liz Cumby⁠⁠⁠⁠⁠About Cumby Consulting:Cumby Consulting's team of professionals deliver innovative MedTech training services for physicians, sales representatives, teaching faculty, key opinion leaders and clinical development teams. Whether you need a complete training system developed to deliver revenue sooner or a discrete training program for a specific meeting, Cumby Consulting will deliver highly strategic, efficient programs with uncompromising standards of quality.

Synopsis: When an introverted engineer becomes the President & CEO of REGENXBIO, transformation follows. Curran Simpson joins host Rahul Chaturvedi to unpack his unlikely journey from biotech operations to the C-suite—and how that hands-on experience is reshaping gene therapy's future. They dive into the evolution of REGENXBIO's pipeline, tackling ultra-rare diseases like MPS II, ambitious plans for Duchenne Muscular Dystrophy, and commercial partnerships with giants like AbbVie. Curran offers hard-earned leadership lessons, honest reflections on scaling science, and insights into how one-time gene therapies could revolutionize treatment in both rare and common diseases. From clinical nuance to strategic boldness, this is a masterclass in biotech leadership, platform focus, and staying patient-first—no matter how complex the science or market. Biography: Curran M. Simpson is the President and Chief Executive Officer and member of the Board of Directors at REGENXBIO. Mr. Simpson previously served as the Company's Chief Operating Officer. In that role, he led key business functions including Research & Clinical Development, Corporate Strategy, Manufacturing & Quality, Regulatory, and Commercial Operations. Mr. Simpson joined REGENXBIO in 2015 with extensive leadership experience across biopharmaceutical operations and served as the Company's Chief Technology and Operations Officer before becoming COO. Prior to joining REGENXBIO, he was the Regional Supply Chain Head for North America and Interim Chief Operating Officer at GlaxoSmithKline (GSK). Mr. Simpson earlier served as interim CEO of Human Genome Sciences (HGS), where he led the integration of HGS into GSK, and as Senior Vice President of Operations and Vice President of Manufacturing Operations at HGS. Prior to HGS, Mr. Simpson was Director of Manufacturing Sciences at Biogen. Earlier in his career, Mr. Simpson served in an overseas assignment at Novo-Nordisk Biochem in Denmark and in various senior development and engineer roles at Genentech, working on Herceptin and Avastin, among other roles. Mr. Simpson has an M.S. in surface and colloid science from Clarkson University and a B.S. in chemistry from the Clarkson College of Technology.

In this episode we talk with Piete Casius, President & CEO of Friendship Industries. Living in the Shenandoah Valley since 2008, he shares the journey that brought him to Virginia and eventually to his leadership role. Starting as Director of Commercial Operations at Friendship Industries in 2016, Piete reflects on how working at a nonprofit has shaped him personally—and the meaningful impact the organization has on the community.

Have you ever wondered what it's like to look after the elephants at Dublin Zoo? From training them to giving them pedicures, elephants can be very high maintenance. Christina Murphy is the Elephant Team Leader at Dublin Zoo and she told Pat what that's like. Also joining us is Jenny Dunne, Head of Commercial Operations who is going to talk to us about all the upcoming events happening here at Dublin Zoo from the Zoorassic Trail Takeover to their first ever Run for Wildlife.The show today was live from Dublin Zoo as part of Newstalk Summer Tour 2025 with thanks to ESB's 1600 EV chargers across Ireland giving you the freedom to go further.

ENTREPRENEURS Topic: The companies driving township logistics nationwide Guest: Ashlin Govender, Head of Commercial Operations at Delivery Ka Speed

How do you market sensitive women's health products when advertising platforms won't let you talk about them? In this episode, Stewart Gandolf and Debbie Donovan, Head of Commercial Operations at Materna Medical, explore the unique challenges of marketing products that address women's health issues, such as vaginal muscle tightness, pelvic organ prolapse, and painful sex.

This week I had the pleasure of speaking with Lioba Oerter, Director of Expert Services, 3E Expert Service Processing Centre (ESPC), and Karin F. Baron, Director of Hazard Communication and International Registration Strategy at B&C and our consulting affiliate, The Acta Group, about the significant changes to product classification, labeling, and packaging (CLP) in the European Union (EU). Lioba and I shared a podium recently and found we also have a shared belief that these forthcoming CLP changes will have a profound commercial impact on product classification, labeling, and packaging globally and that with everything going on in the world these days, this impact may be a bit underappreciated. Karin and I spoke about these matters last year, and I welcomed an opportunity to consider them again with Karin and Lioba in light of the new CLP developments as of December 2024. Karin, Lioba, and I discuss the CLP changes, including those recently made, why they came to be, what they mean for commercial operations, and conclude with some tips on staying ahead of this coming storm. ALL MATERIALS IN THIS PODCAST ARE PROVIDED SOLELY FOR INFORMATIONAL  AND ENTERTAINMENT PURPOSES. THE MATERIALS ARE NOT INTENDED TO CONSTITUTE LEGAL ADVICE OR THE PROVISION OF LEGAL SERVICES. ALL LEGAL QUESTIONS SHOULD BE ANSWERED DIRECTLY BY A LICENSED ATTORNEY PRACTICING IN THE APPLICABLE AREA OF LAW. ©2025 Bergeson & Campbell, P.C.  All Rights Reserved

2025 7th Annual Capital Link Singapore Maritime Forum | Charterer’s Perspective The Forum sought to underscore Singapore's pivotal role as a gateway to Asia and a key player in the global shipping markets. It explored key developments and emerging trends in energy, commodities, and various shipping sectors, alongside insights into the global financial and capital markets. The agenda also addressed critical topics such as global trade, regulatory advancements in shipping, digitalization, technological innovation, and energy transition. Moderator: Ms. Evie Jenie, Legal Director – Hill Dickinson Panelists: • Mr. Peter Lye, Executive Head of Marketing – Shipping & Safety – Anglo American • Ms. Sarah Greenough, Head of Maritime Enterprise – BHP • Mr. Andrew Hoare, Head of Green Shipping – Fortescue • Mr. Scott Bergeron, Managing Director, Fleet – Oldendorff Carriers • Ms. Laure Baratgin, Head of Commercial Operations – Rio Tinto • Mr. Rodrigo Bermelho, Director, Global Head of Shipping and Distribution – Vale The Forum was held in partnership with ABS, and in cooperation with Columbia Shipmanagement and Singhai Marine Services, and in conjunction with the 2025 Singapore Maritime Week. Tuesday, March 25, 2025 The Westin Singapore More Info: https://shorturl.at/mQL0L #ShippingIndustry #MarineIndustry #ShippingLeadership #MaritimeExperts #Forums #Capitallink #SMW2025

Today we are breaking down Watsco, the market leader in HVAC distribution with a unique value proposition. If you've ever had an air conditioning issue, there's a decent chance it was a Watsco distributor on the other side of that phone call.    My guests today are Lucy Adams, Investment Director at Caledonia Investments, and Alan Murran, Co-Head of Public Companies at Caledonia Investments. Lucy and Alan help track the history of Watsco like the initial pivot from manufacturer to distributor and how Watsco formed relationships with the major OEMs like Carrier. We also dissect their reputation for a strong culture, with what has to be one of the most unique employee compensation plans in effect. Please enjoy this breakdown of Watsco. Subscribe to Colossus Review For the full show notes, transcript, and links to the best content to learn more, check out the episode page here. ----- Business Breakdowns is a property of Colossus, LLC. For more episodes of Business Breakdowns, visit joincolossus.com/episodes. Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com). Show Notes (00:00:00) Welcome to Business Breakdowns (00:03:34) Watsco's Role in HVAC Distribution (00:04:40) Watsco's Business Model and Services (00:06:42) Real-World Example of Watsco's Impact (00:09:28) Market Position and Competition (00:12:55) Historical Evolution of Watsco (00:15:52) Exclusivity Agreements in HVAC Industry (00:18:05) Residential vs. Commercial Operations (00:21:04) Growth Strategies and M&A Philosophy (00:26:45) Carrier Joint Venture and Future Opportunities (00:29:40) Watsco's Multi-Brand Acquisition Strategy (00:31:34) Gross and Operating Margin Expansion (00:33:24) Pricing Strategies and Market Dynamics (00:35:16) Recurring Revenue and Business Model (00:37:36) Cash Flow Management and Capital Allocation (00:40:52) Technology Adoption and Digital Transformation (00:45:50) Incentive Programs and Ownership Culture (00:50:45) Risks and Competitive Landscape (00:55:02) Lessons from Watsco

Industrial Talk is onsite at Accruent Insights and talking to Meelad Nikpourian, Vice President, Commercial Software and Strategy at Accruent about "Innovative suite of solution focused on success". Scott MacKenzie and Meelad discuss the Accruent Insights conference in San Antonio, highlighting Accruent's global customer base and recent acquisitions, including a full SaaS EDMS product from Australia. Meelad, VP of Commercial Operations, explains Accruent's strategy to simplify the buying process and integrate solutions, emphasizing the importance of customer insights. They discuss the integration of Accruent's EDMS with Service Channel, enhancing retail maintenance and predicting asset degradation. Meelad notes the significant financial impact of food spoilage and the potential for insurance integration. Looking ahead, Meelad sees Accruent becoming more global and innovative, with a focus on customer-driven solutions. Action Items [ ] Explore the potential insurance benefits for customers by integrating Accruent's asset monitoring data. [ ] Follow up on expanding Accruent's global reach and customer use cases across different markets. [ ] Connect with Melan on LinkedIn to discuss further opportunities. Outline Accruent Insights Conference Overview Scott MacKenzie introduces the podcast and highlights the importance of celebrating industry professionals. Scott mentions the current event at Accruent Insights in San Antonio, Texas, emphasizing the problem-solving atmosphere. Scott and Meelad discuss the success of the conference and the importance of customer insights in driving solutions. Meelad mentions the new leadership under Richard Lurick and the global reach of Accruent's customer base. Introduction of Speaker 2 and Role Meelad introduces himself as the Vice President of Commercial Operations and Strategy at Accruent. He explains his role in working closely with global go-to-market teams, marketing, sales, and product leaders. Meelad emphasizes the importance of providing a seamless experience for both prospects and customers throughout the buying cycle. He describes the conversion process from lead capture to nurturing and handing over to account executives. Challenges in the Buying Process Scott and Meelad discuss the increasing complexity of the buying process with more stakeholders involved. Meelad highlights Accruent's efforts to reduce complexity by making the buying process easier and integrating solutions. They talk about the importance of providing combined packages that add more value to customers. Meelad clarifies that Accruent still caters to single-point solutions and the importance of integrations with external products. Integration and Customization of Solutions Meelad explains the integration of Accruent's solutions with leading CMS and EDMS products. He emphasizes the importance of providing a holistic solution for customers, regardless of their portfolio. Scott and Meelad discuss the potential for adding value by integrating existing products with new solutions. Meelad mentions the bi-directional integration with Service Channel, a leading CMS for the retail space. Retail Use Case and AI Capabilities Meelad provides a detailed use case for a grocery store using Accruent's solutions to monitor and predict

As part of the Travel Technology Investment Trends 2024 research, we surveyed 1,200 technology leaders from across the travel industry, including hospitality leaders. The research benchmarks how hospitality leaders are making strategic bets on digital transformation. In this episode, we sit down with Maria Taylor, Senior Vice President of Marketing, Partnerships, and Commercial Operations for Hospitality, Amadeus, and Martin Cowen, Contributing Editor to delve into how hospitality leaders are planning their investments for the future. Tune in to this episode to explore: Following the shift to online booking tools in the late '90s, approximately 60% to 65% of hotel room sales are now conducted online, allowing sales teams to focus on high-value tasks that drive revenue. Hotels worldwide are facing significant labor challenges, with 67% reporting staff shortages. 85% of hoteliers believe that personalization can deliver incremental revenue and a much better guest experience. What can we expect in this next exciting chapter of our industry? Tune in to find out. To stay up to date on the latest news from Amadeus, and to catch the next episodes in our series, check out the resource center on our website or follow us on Spotify or Apple podcasts.   To stay up to date on the latest news from Amadeus, and to catch the next episodes in our series, check out the Resource section on our website or follow us on Spotify or Apple podcasts.

Peter Vaughan Schmidt, CEO, Torc joined Grayson Brulte on The Road to Autonomy podcast to discuss how Torc is preparing to launch commercial operations in Texas.Torc's strategic relocation from Albuquerque to Fort Worth, Texas was a move that aligned with changing market dynamics. The regulatory environment combined with a growing demand for freight movement, makes Texas the ideal market to launch s commercial autonomous trucking operations.Looking ahead to 2027, Torc plans to launch commercial autonomous trucking operations in Texas. When the service is launched, customers will purchase autonomous-ready Cascadias from Freightliner, own the asset and subscribe to Torc's virtual driver service.Recorded on Tuesday, January 14, 2025Episode Chapters0:00 Torc Moves from Albuquerque to Texas4:37 Autonomous-Ready Cascadias8:57 Preparing for Driver-Out Operations11:01 Torc's Perception System12:22 From a Robotics Stack to an AI Stack15:26 Autonomous Truck Policy17:08 AI's Is Accelerating Torc's Commercial Launch20:32 Scaling Commercial Operations22:39 Buying an Autonomous Truck Powered by Torc24:24 Torc Business Model30:07 Autonomous Truck Maintenance34:09 Capital Allocation Strategy37:21 Outside Capital39:44 Additional OEMs41:05 Waymo43:29 Autonomous Trucking Market45:17 Torc Outlook--------About The Road to AutonomyThe Road to Autonomy® is a leading source of data, insight and commentary on autonomous vehicles/trucks and the emerging autonomy economy™.Sign up for This Week in The Autonomy Economy newsletter: https://www.roadtoautonomy.com/autonomy-economy/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kathy Fraley retired as the Service Center Director for the Travelers Select Service Center located in Spokane, Washington and Colorado Springs, Colorado. Her teams were responsible for providing direct service to insureds and agents in all states. Kathy has spent more than 30 years in the agents and carrier ranks. Her career started in the underwriting side at a carrier and after 4 years moved to the agency side. Prior to joining Travelers, Kathy retired after 28 years as a partner/owner from Propel Insurance where she held the position of Vice President of Marketing and Commercial Operations located in the Pacific Northwest. Kathy developed a passion for the industry and feels it is important to give back to the industry by teaching. She has been a teacher in the Junior Achievement program and enjoyed working with students as they learned about community involvement. Kathy earned her CIC designation in 1987 and has previously served on the CISR Board of Governors. She also acts as an instructor and Education Consultant for various programs with the Risk & Insurance Education Alliance. Focusing exclusively on risk management and insurance professional development, the Risk & Insurance Education Alliance provides a practical advantage at every career stage, positioning our participants and their clients for confidence and success.

Tom Lyons of The Currency discusses the fall-out for Conor McGregor since he lost the civil rape case taken against him by Nikita Hand.

Daniel Goff, Director of External Affairs, Kodiak joined Grayson Brulte on The Road to Autonomy podcast to discuss what the autonomous trucking industry needs from Washington, D.C. in order to scale commercial operations. Autonomous trucking regulations are often misunderstood. Contrary to popular belief, the legal and policy frameworks for deploying autonomous trucks on U.S. roadways are more advanced than many assume. The necessary regulatory elements are already in place, allowing for immediate deployment and scaling of autonomous trucks. While the necessary regulatory elements are already in place, what does the autonomous trucking industry need from Washington, D.C. to have regularity certainty? Tune in to find out. Episode Chapters0:00 Current State of Autonomous Trucking Regulations 3:58 Investor Thoughts on Autonomous Trucking Regulations 6:11 Public's Perspective on Autonomous Trucks and Vehicles 10:17 Human Trafficking 13:02 Law Enforcement Interaction 20:22 Federal Autonomous Vehicle Framework30:59 National Security Issues 33:41 Tech and Labor Tensions 40:15 Autonomous Trucks in California 44:00 2025 OutlookRecorded on Monday, November 25, 2024--------About The Road to AutonomyThe Road to Autonomy® is a leading source of data, insight and commentary on autonomous vehicles/trucks and the emerging autonomy economy™.Sign up for This Week in The Autonomy Economy newsletter: https://www.roadtoautonomy.com/autonomy-economy/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Welcome to the latest episode of the FocusCore podcast. In this episode we are talking about the field of Genomics and how the applied genomics technology company, Illumina is pushing the boundaries of genomic biotechnology for research and in applied medicine. Our guest is General Manager and Representative Director of Illumina KK, Arjuna Kumarasuriyar. Arjuna has commercial experience in sales, marketing, channel management and commercial operations, as well as an academic background in biotechnology and molecular biology. In the episode we dive deep into what genomics is and how it is evolving, as well as hearing some of Arjuna's insights into Japan's unique business landscape.In this episode you will hear:What the term genomics means and how it differs from geneticsWhat made Arjuna change his study from medicine to biotechnologyAbout Illumina's work in biotechnologyHow the technology Illumina is developing is fundamentally changing healthcare around the worldWhat Arjuna has learnt about doing business in JapanHow AI technology might impact genomicsAbout Arjuna Kumarasuriyar:Arjuna Kumarasuriyar has Commercial experience in sales, marketing, channel management and Commercial Operations in the life sciences sector. The majority of Arjuna's career has been in genomics with Illumina covering business across the Asia Pacific region. The first eight years of his career at Illumina were in sales, marketing and sales management roles. The next eight years he established and grew a commercial operations function to support the rapidly expanding commercial team in Asia through analytics, processes, technology, training and back office functions. Arjuna has been General Manager and Representative Director of Illumina KK since January 2023. He is passionate about finding ways for teams to perform at their best whether it is shaping organizational structures and culture or getting into the operational enablement to enable efficient and effective customer value creation.Arjuna has a Bachelors in Biotechnology and a PhD in Molecular Biology from the University of Queensland, Australia. He joined Illumina in 2007 after working in R&D, quality assurance, and technology transfer roles for several biotech companies and government agencies in Singapore and Australia. Connect with Arjuna Kumarasuriyar:LinkedIn: https://www.linkedin.com/in/arjunakumarasuriyar/X: https://x.com/ArjunaKConnect with David Sweet:LinkedIn: https://www.linkedin.com/in/drdavidsweet/ Twitter: https://twitter.com/focuscorejp Facebook: :https://www.facebook.com/focuscoreasiaInstagram: https://www.instagram.com/focuscorejp/ Website: https://www.japan.focuscoregroup.com/ “Doin' the Uptown Lowdown,” used by permission of Christopher Davis-Shannon. To find out more, check out www.thetinman.co. Support independent musicians and artists.

HLTH brings together all the ecosystem stakeholders each year to discuss the innovations that will help solve some of healthcare's biggest challenges. In this podcast episode, Noe Gutierrez, the Head of Commercial Operations at Genoplex, Inc., shares many of the key themes and insights from the biggest health tech conference of 2024.

Grace Hyde is the Director of Commercial Operations for District Cannabis, a thriving cultivator providing premium flower to the Washington D.C. and Maryland markets. Grace oversees innovation across the company. In addition, she is responsible for government relations in Washington, D.C., and operational oversight of the D.C. cultivation facility. She previously held management positions in wholesale and retail cannabis operations in D.C. and Rhode Island. She discusses topics such as the regulatory and market challenges facing retail cannabis operations in DC and Maryland and exciting developments at District Cannabis, a trusted brand of high-quality cannabis products in DC and Maryland.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

In this episode of the Chamber Vibes podcast, host Foster Garrett introduces guests Bill Moss and Micah from Foster Fuels. Bill, a long-time board member and Manager of Commercial Operations for Propane, shares his journey from being a pilot to joining Foster Fuels, emphasizing the company's commitment to customer service. Micah, the Propane Marketing Manager, discusses his marketing background and focus on residential propane growth. They highlight Foster Fuels' diverse services, community engagement, and emergency response efforts. The episode also explores the role of propane in off-grid living, showcasing its versatility and reliability.

In this episode of Life Science Success, we welcome Ani Sinha, the Vice President of Commercial Operations at Shionogi Inc. Ani brings nearly 15 years of deep commercial expertise in the pharmaceutical and biotech industries. She shares her inspiring journey from studying microbiology and biochemistry at Yale and Columbia to holding strategic leadership roles at companies like Pfizer, Bayer, and Celgene. We delve into her current role at Shionogi, exploring how she leads functions like Analytics and Insights, Market Research, and Field Operations. Ani discusses the innovative projects she's excited about and how they're contributing to Shionogi's mission. She also shares the greatest piece of leadership advice she's ever received and opens up about what inspires, concerns, and excites her in the world of life sciences. Tune in to gain valuable career insights and explore the dynamic future of pharmaceutical advancements.   00:00 Introduction to Life Science Success Podcast 00:42 Sponsor Message: D3 Digital Media Marketing 01:25 Interview with Ani Sinha Begins 02:08 Ani Sinha's Career Journey 05:18 Transition from Lab to Consulting 07:58 Skills Gained from Management Consulting 11:25 Joining Shinogi and Role in Commercial Operations 20:13 Future of Commercial Operations 22:21 Building a Team: The Land of Misfit Toys 23:02 Navigating Different Companies and Roles 24:05 The Evolving Role of Analytics and Insights 25:41 Challenges in Market Research and Operations 29:32 Addressing Trends in Biotech and Pharma 32:13 Greatest Leadership Advice Received 34:44 Inspiration and Concerns in the Pharma Industry 40:52 Final Thoughts and Farewell

In this episode, we have a conversation with Cam McKenzie, VP of Commercial Operations at PacBio and a leader in the genomics and life sciences industry. McKenzie discusses the innovative transformation of PacBio's commercial operations under the guidance of CEO Christian Henry, focusing on overcoming challenges like siloed operations and minimal infrastructure through strategic Salesforce integration and omnichannel strategies.  We also delve into the potential for innovation at the intersection of technology and human collaboration. McKenzie emphasizes the importance of fostering a culture of continuous learning and adaptability to stay ahead in the rapidly evolving field of genomics. Show Highlights: Strategic transformation of PacBio's commercial operations, focusing on Salesforce integration and omnichannel strategies. Challenges faced by PacBio and the innovative solutions implemented. Insights into the complexities of PacBio's business model. The impact of technology in streamlining sales processes and improving customer interactions. Reflection on the importance of diverse perspectives and optimism for future innovation at the intersection of technology and human collaboration. Follow and Review: We'd love for you to follow us if you haven't yet. Click that purple '+' in the top right corner of your Apple Podcasts app. We'd love it even more if you could drop a review or 5-star rating over on Apple Podcasts. Simply select “Ratings and Reviews” and “Write a Review” then a quick line with your favorite part of the episode. It only takes a second and it helps spread the word about the podcast. Supporting Resources: Join the Commerce Cloud Community: http://sforce.co/commercecrew To learn more about Commerce Cloud Innovations, go here: https://www.salesforce.com/commerce/innovations/  Would you like to be on the podcast, or do you know someone who should? Check out the nomination form: http://sfdc.co/podnomination  *** Episode Credits If you like this podcast and are thinking of creating your own, consider talking to my producer, Emerald City Productions. They helped me grow and produce the podcast you are listening to right now. Find out more at https://emeraldcitypro.com. Let them know I sent you.

Two years after the announcement that Veeva and Salesforce would part ways, Life Sciences organizations are racing to evaluate their options and select their CRM partner before the 2025 cutover. Jen is joined by Vynamic's Life Sciences Commercial Operations Lead, Jeremy Shirey, and Tech & Digital Transformation Service Lead, Vince Annerhed-Harris as well as special guests, CodeScience's CEO, Mike Utell, and Chief Revenue Officer, Sean Hogan, to discuss how Life Sciences leaders should approach this decision and transition to minimize disruption and maximize business value.For more information about CodeScience, visit their website: https://www.codescience.com/For more information about Vynamic's work in Commercial Operations and Tech & Digital Transformation, visit: https://vynamic.com/ Podcast Tags: healthcare, life sciences, healthcare technology, healthcare news, Veeva, Salesforce, tech and digital transformation, CRM, commercial operations, CodeSciencePanel – Jen Burke, Jeremy Shirey, Vince Annerhed-Harris, Mike Utell, Sean HoganResearch & Production – Jen Burke, Jeremy Shirey, Vince Annerhed-HarrisRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Louis Zweig, Southen Glazer's Wine & Spirits SVP of Commercial Operations, dives into the buzz around celebrity brands and why they're shaking up the beverage world. He speaks about championing craft brands and the innovation they bring, highlights market diversity, & shares his incredible journey through the beverage world

Zandy Forbes, Founder, President, and CEO of MeiraGTx, joins host Rahul Chaturvedi in this compelling episode. Zandy shares her inspiring journey from academia, where she developed a deep interest in molecular biology and genetics, to her significant role in biotech investing, and eventually leading a groundbreaking gene therapy company. She elaborates on Meira's cutting-edge approach to genetic medicines, focusing on the development of innovative therapies for non-inherited diseases. Zandy discusses the unique challenges and opportunities that arise in the biotech sector, shedding light on the strategies Meira employs to navigate this complex landscape. Biography: Alexandria Forbes, Ph.D. is the President and CEO of MeiraGTx (NASDAQ: MGTX). MeiraGTx is a vertically integrated gene therapy company with core capabilities in viral vector design and optimization and gene therapy manufacturing, as well as a potentially transformative gene regulation technology. The company is developing innovative gene therapy products to cost effectively treat a range of serious medical disorders, with clinical programs currently in the eye, salivary gland and CNS. Prior to founding MeiraGTx, Dr. Forbes served as Senior Vice President of Commercial Operations at Kadmon Holdings, Inc., a biopharmaceutical company, from September 2013 to April 2015.Before joining the biotech industry, she spent 10 years as a healthcare investor at Sivik Global Partners (Argus Partners) and Meadowvale Partners. At Sivik, Dr. Forbes was responsible for investments in biotechnology, specialty pharmaceuticals and diagnostics public equities and was portfolio manager of the Sivik Global Life Science Fund, a long-biased public markets fund investing in biotechnology companies globally. During her time as a biotechnology investor, Dr. Forbes covered over 300 companies and gained expertise in biotechnology business strategies and clinical drug development as well as a wide range of disease areas. Particular areas of focus included HIV, HCV, diabetes, obesity, autoimmune disorders, cancer, Alzheimer's disease, kidney disease and liver disease. Before entering the hedge fund industry, Dr. Forbes was an academic scientist studying the regulation of stem cell identity and different aspects of embryogeneis. She was a Human Frontiers/Howard Hughes postdoctoral fellow at the Skirball Institute of Biomolecular Medicine at NYU Langone Medical Center, where her research focused on cytoplasmic determinants and cell signaling pathways involved in the migration, establishment and maintenance of germ line stem cells in Drosophila melanogaster. Prior to this, Dr. Forbes was a research fellow at Duke University and at the Carnegie Institute at Johns Hopkins University where she studied the role of the hedgehog gene and its signaling pathway in the Drosophila embryo and adult. Dr. Forbes received her Ph.D. in Molecular Genetics from Oxford University, UK and attained a double first degree in Natural Sciences from Cambridge University, UK. Dr. Forbes serves on the Board of Directors of MeiraGTx, and as a Trustee and Director of the Selfridges Group Foundation, the European arm of the Weston Brain Institute, a charity supporting research into neurodegenerative diseases with the aim of speeding the time to the development of disease modifying treatments for these currently intractable diseases, particularly Alzheimer's.

The concept of an ESOP to me has always seemed extraordinary yet at the same time a little hard to grasp. E-S-O-P is an acronym for Employee Stock Ownership Plan. Basically it means an employee owned company. Our guest on today's podcast is Rich Gaffney, Vice President of Commercial Operations at Sentry Equipment, a 100-year-old [...] The post What If The Employees Owned Your Company?, with Rich Gaffney–EP 220 first appeared on Today's Machining World.

On this episode of the Bama Means Business Podcast, Scott Reel, Senior Vice President of Commercial Operations at Southern Company, shares his career journey and insights into the utilities industry. Scott discusses his responsibilities, from short-term electricity demand forecasting to fuel management for power plants. Reflecting on his transition from accounting to a commercial role, Scott highlights the importance of intellectual curiosity, teamwork, and effective communication in advancing one's career. He also emphasizes the value of forming relationships and networking, staying open-minded, and continuously learning. Additionally, Scott provides thoughtful advice on work-life balance, choosing the right career path, and making the most of opportunities in and out of the workplace. The episode concludes with Scott reminiscing about his time at the University of Alabama and the impact of the university's alumni network on his professional life.For more information about the Culverhouse College of Business visit our website https://culverhouse.ua.edu.Stay up to date with the collegeFacebook: https://facebook.com/culverhouseuaTwitter: https://twitter.com/culverhouseuaInstagram: https://instagram.com/culverhouseuaLinkedIn: https://linkedin.com/school/culverhouse-college-of-business 

All in 24 Minutes or less… In Season 5, Episode 2, Travis sits down with Kurt Hunzeker, Executive Vice President of Commercial Operations at the National Lacrosse League. Kurt has gained a great amount of experience in brand, team, and league side of the business. Tune in to hear all of the excitement that is surrounding the sport of lacrosse. 3 Hot Topics: ✅ Sharing Best Practices ✅ Key Characteristics  ✅ Future of the NLL www.52weeksofhustle.com Book Available - https://www.amazon.com/dp/1735610801 Learn more about your ad choices. Visit podcastchoices.com/adchoices

In the final episode of MedtechWOMEN Talks season one, we are joined by YJ Oh, SVP US Sales, Marketing and Commercial Operations at Edwards Lifesciences, who takes us through the intricate process of medical device commercialization. Starting with her unique entry into the medtech industry, YJ shares her comprehensive journey from sales to global marketing, emphasizing the significant role of upstream marketing in shaping product development and downstream efforts in executing commercial strategies. In the discussion, YJ highlights the criticality of understanding market needs right from the inception of a product idea, ensuring that every development phase aligns with customer insights and real-world applicability. She provides a glimpse into the key collaborations across various departments and touches on the essential feedback mechanisms in place, ensuring devices meet the stringent requirements and expectations set forth by both regulatory bodies and the end-users, primarily physicians. Her insights extend into the strategic considerations for global market penetration, discussing how different regulatory landscapes affect the accessibility and success of medical devices across borders. TL;DR – Key Takeaways: - The integration of market insights from the beginning is crucial for successful medical device commercialization. - Collaborative efforts across various functions are vital to address the comprehensive demands of product development. - Strategic global considerations are imperative to navigate varying regulatory and market conditions effectively. Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical! https://aptyx.com/ https://catalyzehealthcare.com/ https://confluentmedical.com/ https://www.cretex.com/ Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to MedtechWOMEN Talks!

In this episode, we speak with Bas van Wijk, VP Commercial Operations, AskCody, the Meeting Management Platform for Microsoft that's driving meeting efficiency through an intelligent Meeting Management and Resource scheduling Platform, and has helped shape the relationship between real estate, organizations, and technology at more than 2500 offices globally. We talked with Bas about getting your inbound lead engine going! In particular, we are looking into the process of some of the early steps in this process: - Per definition, what does it mean to be an inbound-driven business? - What are the main difficulties moving from a sales-led to a marketing/inbound-led approach? - Which are some of the very steps to take here, and why in that order? - How do you manage the potential revenue gap that may take place in a transition period? - What changes does this require to a team and org structure that previously was sales-led? - What effects does it have on revenue predictability? These are some of the many questions we address with Bas. Please tune in to hear how Bas successfully executed this transition and now operating a fully inbound-led business, sharing his learnings along the way.

On this episode of Chit Chat Stocks, Brett pitches Ryan on GoGo, an inflight internet provider for private jets. Listen to the full show to see if he is buying shares. On the episode, we cover: (00:00) Introduction to GoGo and its Misleading Name (03:02) Background and Financial History of GoGo0 (6:11) GoGo's Exclusive Spectrum and CEO Change (09:44) Sale of Commercial Operations and Financial Position (14:06) GoGo's Services for Business Jet Customers (31:29) Upgrade to 5G and Low Earth Orbit Solution (35:14) Financial Situation (39:31) Competition and Moat (51:58) Cashflow Inflection and Upside Potential (55:07) Management and Trust (56:53) Valuation and Buying Decision (59:25) Risks Stocks discussed: GOGO ***************************************************** Subscribe to our YouTube channel: https://www.youtube.com/@ChitChatStocks  Follow us on Twitter/X: ⁠https://twitter.com/chitchatstocks  Follow us on Substack: ⁠https://chitchatstocks.substack.com/  ********************************************************************* Options are not suitable for all investors and carry significant risk.  Option investors can rapidly lose the value of their investment in a short period of time and incur permanent loss by expiration date.  Certain complex options strategies carry additional risk.  There are additional costs associated with option strategies that call for multiple purchases and sales of options, such as spreads, straddles, among others, as compared with a single option trade. Prior to buying or selling an option, investors must read and understand the “Characteristics and Risks of Standardized Options”, also known as the options disclosure document (ODD) which can be found at: www.theocc.com/company-information/documents-and-archives/options-disclosure-document Supporting documentation for any claims will be furnished upon request. If you are enrolled in our Options Order Flow Rebate Program, The exact rebate will depend on the specifics of each transaction and will be previewed for you prior to submitting each trade. This rebate will be deducted from your cost to place the trade and will be reflected on your trade confirmation. Order flow rebates are not available for non-options transactions. To learn more, see our Fee Schedule, Order Flow Rebate FAQ, and Order Flow Rebate Program Terms & Conditions. Options can be risky and are not suitable for all investors. See the Characteristics and Risks of Standardized Options to learn more. All investing involves the risk of loss, including loss of principal. Brokerage services for US-listed, registered securities, options and bonds in a self-directed account are offered by Open to the Public Investing, Inc., member FINRA & SIPC. See public.com/#disclosures-main for more information. ********************************************************************* FinChat.io is The Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, FinChat is incredibly powerful and easy to use. Use our LINK and get 15% off any premium plan: ⁠https://finchat.io/chitchat/?lmref=J3bklw  ********************************************************************* Check out https://www.firmreturns.com/ for value-focused equity research  Use our link and get a 20% discount on a premium plan: firmreturns.com/chitchat  ********************************************************************* Disclosure: Chit Chat Stocks hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation.

In this episode of BRAVE COMMERCE, Mir Zaman, Vice President of Commercial Operations at Spectrum Brands, joins hosts Rachel Tipograph and Sarah Hofstetter to provide insights on leadership, innovation, and adaptability, offering strategies for navigating dynamic business landscapes effectively.The discussion starts with Mir introducing Spectrum Brands, a company operating in three diverse industries: Home and Personal Care, Home and Garden, and Pet Care. He highlights key brands in the company's portfolio, providing context for understanding the extensive range of consumer products offered by Spectrum Brands.The conversation then delves into Mir's unconventional career path, beginning with his childhood dream of working in aerospace engineering, to roles at Boeing, NASA, and eventually Amazon. His transition into the eCommerce realm at Amazon, despite initial reservations, highlights his adaptability and problem-solving prowess, both integral to his leadership philosophy.Mir emphasizes the significance of curiosity, data-driven decision-making, and a commitment to continuous experimentation in navigating complex business landscapes. He also reflects on the seamless integration of his experiences into his current role at Spectrum Brands, highlighting the importance of augmenting organizational cultures rather than imposing radical transformations.In conclusion, Mir talks about his strategic vision for Spectrum Brands and his focus on fostering collaboration across teams and aligning efforts with overarching business objectives. He also shares insights into decision-making frameworks, akin to an engineering approach, that prioritize inputs and outputs to achieve desired outcomes.Key Takeaways:● Embrace curiosity as a leadership skill for problem-solving and innovation● Empower teams with ownership and accountability tied to revenue and cost objectives● Apply a profit and loss mindset to decision-making, analyzing inputs and outputs to determine the best course of action Hosted on Acast. See acast.com/privacy for more information.

Welcome to BCI Cattle Chat! In this episode guest, Adrienne Lulay, and the experts discuss tips for AI success, heat detection vs. timed breeding and sexed semen in commercial operations. This episode is sponsored by Estrotect. We Want to Hear From YouThe Beef Cattle Institute team would like to hear your thoughts about the Cattle… Continue reading Tips for AI Success, Heat Detection vs. Timed Breeding, Sexed Semen in Commercial Operations

$PTPI Petro Pharma CCO – Fady Boctor – How To Take Smart Risks, Intelligently Guest: Fady Boctor, M.B.A, President and Chief Commercial Officer Website: PetrosPharma.com Bio Mr. Boctor has over 20 years of experience in the pharmaceutical industry, across a wide array of functions including Commercial Operations, brand and portfolio marketing, sales channel optimization, product portfolio strategy development and new product launches. Mr. Boctor has driven significant revenue growth for specialty biologics, mainstream Men's Health product lines, rare/orphan disease therapeutics, and substance abuse rescue modalities. Mr. Boctor has worked for companies such as Novartis, Merck, Auxilium Pharmaceuticals, Endo Pharmaceuticals and Adapt Pharmaceuticals (Emergent Biosolutions). Mr. Boctor has his BA in International Relations from Hamline University, Masters in Diplomacy from Norwich University and his MBA from the University of Manchester Business School. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Matt Bachman is in charge of the Commercial Operations for Milestone Pharmaceutical company, a biotech company launching a novel treatment for patients with PSVT. Jasmeet and Matt discuss the intricacies of building a commercial function for an emerging pharma company, with Matt highlighting distinctions between working in a large pharmaceutical company versus a smaller one. They also delve into crucial factors influencing decision-making for the future, with a particular emphasis on the formidable challenge of navigating data considerations. Matt introduces a compelling and reflective concept, emphasizing that decisions must be "Fit for Purpose.” That is sound learning, no matter the size of your organization.    IN THIS EPISODE: [2:32] Matt discusses the key differences between working for large pharmaceutical companies and his current position [3:41] Matt explains his vision for setting up the commercial function [5:50] Matt discusses how he decides what priorities are needed for Milestone to benefit the company  [8:05] Matt shares what components he wants to implement to build a foundation for data-driven commercialization, and he is developing a data governance system [13:16] Matt speaks to the technologies and capabilities that they are planning for the future and how he is putting his team together  [17:27]  Matt shares what he has learned in the process of setting up the commercial function KEY TAKEAWAYS In a smaller company, when you don't have the resources of a large entity, you have to determine the must-haves and what things would be nice to have. You need to be able to make adjustments quickly for growing or scaling back.  Connecting with stakeholders, department heads, and other management figures in a smaller organization is more straightforward. The absence of a sprawling corporate structure, as seen in larger companies, facilitates smoother and faster communication.   A company can make a big mistake by spending resources on collecting data, and then they find out it needs to be more accurate data. The perfect time to make data governance decisions is when you are starting out before you start collecting massive amounts of data you won't ever use.    BIOGRAPHY:  Matt Bachman brings over 20 years of experience in the insights and analytics arena at both large pharma and small biotech companies. During that time, he has worked closely with brand teams to commercialize numerous drugs in multiple therapeutic areas. These include drugs for type 2 diabetes and cardiovascular drugs that were first in class and novel therapies, as well as the ones that had little clinical differentiation, which presents its own set of challenges. From a customer standpoint, he has worked on commercializing drugs that targeted specialists and also the ones that targeted broad-based PCPs. He currently leads the commercial operations for Milestone Pharmaceuticals, a small biotech company launching a novel treatment for patients with PSVT. Before Milestone, Matt worked for large companies like GSK and BMS. YOUR HOST: JASMEET SAWHNEY    Jasmeet Sawhney is a life sciences industry executive, marketing leader, and serial entrepreneur with deep roots in technology and data analytics. He is currently the global head of marketing at Axtria. Jasmeet has over 20 years of experience in the life sciences domain and has helped build and scale three successful companies. He has received several company and individual awards, including Inc 500, Deloitte Fast 500, Crain's NY Fast 50, NJBiz Fast 50, Business of the Year, SmartCEO Future 50, Top CMO, Forty Under 40, and many more. Jasmeet Sawhney - LinkedIn Axtria on LinkedIn Matthew Bachman - LinkedIn  

Eileen Maus manifested an incredible career by finding her passion, recognizing her strengths, trusting the process, working hard and honoring the journey.  CEO of Axena Health, Eileen brings 20 years as a healthcare industry sales and marketing executive with strategic planning experience to her role as Chief Executive Officer with Axena Health. Eileen entered the women's healthcare space during her 12 years with Cytyc Corporation, where she was a key contributor to Cytyc's growth from $8 million to over $700 million, holding leadership roles from sales management to Vice President, Commercial Operations of the Surgical Division. Specifically, Eileen built and managed sales forces for five new product launches, including the ThinPrep® Pap Test, ThinPrep® Imaging System, FirstCyte Breast Test, NovaSure Endometrial Ablation, and Mammosite Targeted Radiation Treatment. In addition, Eileen spearheaded the integration and commercialization of Cytyc's surgical division. Prior to Axena Health, Eileen served as CEO of Renovia, Inc. the medical device company who developed and first commercialized the Leva® Pelvic Health System, and as Chief Commercial Officer of Constitutional Medical Investors, a portfolio company of Warburg Pincus. In addition to participating in the diligence of diagnostic companies for potential acquisition, she developed the commercial plan for a disruptive technology in the hematology space that was acquired by Roche Diagnostic. Eileen is a graduate of LaSalle University, with a Bachelor of Science in Marketing and Communications.  Eileen's favorite quote is: “Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it's the only thing that ever has.” – Margaret Meade    What You Will Hear in This Episode  2:37 Eileen's personal story 12:15 Major challenges Eileen has had to face.  Balancing motherhood 18:08 Attributes of a woman led company and Eileen's philosophy as a CEO 28:11 Setting expectations and setting limits/boundaries   Quotes “The journey is what it's about, it's not about reaching the pinnacle of the mountain because as soon as you do that, you want the journey back again.” “Put yourself out there, give yourself a chance. It's okay to fail. That's how we learn, and then just get right back up.” “Don't be afraid of feedback, welcome it.”   Mentioned  Leva Therapy Axena Helath Inc. Ozarks   eConnect with Bonnie https://bonniemarcusleadership.com/ https://web.facebook.com/bonnie.marcus/  https://www.linkedin.com/in/bonniemarcus https://twitter.com/selfpromote https://www.instagram.com/self_promote_/ Gendered Ageism Survey Results Forbes article 5 Tips to own the superpower of your age IAMMusicGroup   Purchase my book Not Done Yet on Amazon:  If you enjoyed this episode of Badass Women Podcast, then make sure to subscribe to the podcast and drop us a five-star review.

Andy Moye is a seasoned commercial leader and corporate development executive who has worked across the molecular diagnostics, biotechnology and life sciences industries. He is currently Chief Executive Officer at Paige and previously served as Chief Commercial Officer, where he led the company's clinical sales and commercial strategy, including the U.S. launch of Paige Prostate, the first and only AI-based pathology product to receive FDA approval for in vitro diagnostic (IVD) use in detecting cancer in prostate biopsies. Previously, Moye served as Head of Commercial Operations in North America and Latin America for the Digital and Computational Pathology division of Philips, delivering significant growth in both markets for the emerging business. Moye has also served in executive roles at leading healthcare companies, including Ontada, a division of McKesson, Caris Life Sciences, and WaferGen Bio-systems, now part of Takara Bio. Prior to joining the industry, Moye served as a Lieutenant and flight officer in the U.S. Navy, completing missions in Bosnia, Kosovo, Iraq, Europe, and South America. He received a Ph.D. in health economics from Walden University, MBA from the University of Florida and B.S. in physiology from the University of Arizona.